The upcoming Westminster Health Forum seminar 'Cancer care in England - access to treatment, improving diagnosis and implementing the NHS Long Term Plan' will be an opportunity to discuss cancer care in England - looking at access to treatment, improving diagnosis and implementing new policy initiatives.

The seminar takes place in the context of the NHS Long Term Plan and the £400m additional funding for Cancer Alliances by 2023/24 to support ambitions within the Plan, including an increase in the diagnosis of cancer at stages 1 and 2 to three quarters of patients by 2028.

Attendees will discuss the next steps for improving cancer screening in England, the developing role of genomics, improving quality of cancer care, the role of Artificial Intelligence in diagnostics, developing the cancer care workforce, and the expansion of multidisciplinary teams.

Another area of discussion will be the development of cancer drugs - looking at long-term investment, collaborative research and improving access to medicine.

Further sessions will look at the progress of the Cancer Drugs Fund, the impact of evidence compiled through data collection and the opportunities to increase managed access to innovative cancer treatments - including CAR T-cell therapy for adults with lymphoma, which was made accessible through the Cancer Drugs Fund earlier this year.